UNIPHAR’S SHARE SLIDE DEMANDS NEW PRESCRIPTION

Maurice Pratt

FOUR YEARS after floating in Dublin, Uniphar has grown significantly but suffered a significant setback when its attempted takeover of Navicorp was shot down at the end of 2022. Although the group’s market presence internationally has been expanding, the shares have been underperforming and there is little sign of the right medicine being prescribed to… Read more »